Anesthesia of hypertensive patients;Anesthésie du malade hypertendu

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue 10, 2004, Pages 979-985

  Berroeta C ^b   Provenchere S ^b   Quintard, H ^b   Ibrahim, H ^b   Faquin, S ^b   Philip, I ^a  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESMOLOL; LABETALOL; NICARDIPINE; TROPONIN; URAPIDIL; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANESTHESIA; ANESTHESIA COMPLICATION; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; HEART INFARCTION; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; ORGAN INJURY; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TARGET ORGAN DAMAGE;

ANESTHESIA, GENERAL; CORONARY ARTERIOSCLEROSIS; HUMANS; HYPERTENSION; MONITORING, PHYSIOLOGIC; MYOCARDIAL ISCHEMIA; PREOPERATIVE CARE; RISK FACTORS;

EID: 7644237587     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.
2. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-83.
3. Recommondations pour la pratique clinique. Prise en chorge des patients adultes atteints d'hypertension artérielle essentielle. ANAES, avril 2000. Disponible sur: http://www.anaes.fr.
4. Poussées hypertensives de l'adulte: élévation tensionnelle sans souffrance viscérale immédiate et urgences hypertensives. AFSSAPS, mai 2002. Disponible: www.atssaps.sante.fr.
5. Frohlich ED. The necessity far recognition and treatment of patients with «mild» hypertension. J Am Coll Cardial 1999; 34: 1369-77.
6. Staessen JA, Thijs L, O'Brien ET et al. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens 2002; 15: 835-43.
7. Vasan RS, Beiser A, Seshadri S et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287: 1003-10.
8. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-15.
9. Staessen JA, Wang JG, Birkenhager WH. Outcome beyond blood pressure control? Eur Heart J 2003; 24: 504-14.
10. Kinney MA, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 2002; 16: 359-69.
11. Gimenez-Roaueplo AJ, Jeunemaitre X. Génétique et hypertension artérielle essentielle: gènes candidats ou criblage du génome entier? Arch Mal Cœur 2003; 96: 1089-95.
12. Henrian D, Benessiano J, Iglarz M, Philip I, Levy BI. Genetic determinants of vascular reactivity. Curr Hypertens Rep 2002; 4: 41-8.
13. Philip I, Plantefeve G, Vuillaumier-Barrot S et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular respansiveness to phenylephrine. Circulation 1999; 99: 3096-8.
14. Ziegeler S, Tsusaki BE, Collard CD. Influence of genotype on perioperative risk and outcome. Anesthesiology 2003; 99: 212-9.
15. Samain E, Clichet A, Bouillier H et al. Propofol differently alters vascular reactivity in normotensive and hypertensive rats. Clin Exp Pharmacol Physiol 2002; 29: 1015-7.
16. Brabant SM, Bertrand M, Eyraud D, Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999; 89: 1388-92.
17. Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg 1999; 89: 1143-55.
18. Eagle KA, Berger PB, Calkins H et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39: 542-53.
19. Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the medicare population. Anesth Analg 1999; 89: 849-55.
20. Fleisher LA, Eagle KA. Clinical practice. Lowering cardiac risk in noncardiac surgery. N Engl J Med 2001; 345: 1077-82.
21. Adams JE, 3rd, Sicard GA, Allen BT et al. Diognosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Enal J Med 1994; 330: 670-4.
22. Lasocki S, Pravenchere S, Benessiano J et al. Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery. Anesthesiology 2002; 97: 405-11.
23. Lopez-Jimenez F, Goldman L, Sacks DB et al. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. J Am Coll J Cardiol 1997; 29: 1741-5.
24. Lee TH, Marcantonio ER, Mangione CM et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9.
25. Kertai MD, Boersma E, Bax JJ et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003; 89: 1327-34.
26. Kertai MD, Klein J, van Urk H, Bax JJ, Poldermans D. Cardiac complications after elective major vascular surgery. Acta Anaesthesiol Scand 2003; 47: 643-54.
27. Landesberg G, Mosseri M, Wolf YG et al. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surqery. Circulation 2003; 108: 177-83.
28. Boersma E, Poldermans D, Bax J et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardioqraphy, and beta-blocker therapy. JAMA 2001; 285: 1865-73.
29. Dix P, Howell S. Survey of cancellation rate of hypertensive patients underqoinq anaesthesia and elective surqery. Br J Anoesth 2001; 86: 789-93.
30. Piriou V, Aouifi A, Lehot JJ. Perioperative beta-blockers. Part two: therapeutic indications. Can J Anaesth 2000; 47: 664-72.
31. Piriou V, Aouifi A, Lehot JJ. [Perioperative beta-blockers. Part one: fundamentals]. Can J Anaesth 2000; 47: 653-63.
32. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335: 1713-20.
33. Poldermans D, Boersma E, Bax JJ et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiography Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-94.
34. Poldermans D, Boersma E, Bax JJ et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001; 22: 1353-8.
35. Cittanova ML, Zubicki A, Savu C et al. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth Analq 2001; 93: 1111-5.
36. Ryckwaert F, Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1997; 84: 945-9.
37. Reynayd C, Provenchère S, Tcherev, V, Desmonts, JM, Philip I. Chronic inhibition of renin-angiotensin system before normothermic cardiac surqery impairs neither hemodynamic variables nor renal function. Anesthesiology 2003; 99: A-233.